For the Inventor, By the Inventor

Enter assignee name

Lake Forest, IL, United States of America

Horizon Orphan LLC

USPTO Granted Patents = 18

% Expired Patents = 22.2

CIPO Patents = 1

EPO Patents = 9

Trademarks = 2

Forward Citations = 35

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Michael N Dudley (8 out of 36 patents)

David C Griffith (8 out of 36 patents)

Olga Rodny (5 out of 27 patents)

4. Todd C Zankel (5 out of 16 patents)

5. Mark William Surber (4 out of 37 patents)

6. Keith A Bostian (4 out of 17 patents)

7. Mark Johnson (4 out of 4 patents)

8. Olga Lomovskaya (3 out of 19 patents)

9. Michael A Desjardin (3 out of 10 patents)

10. Jeffery S Loutit (3 out of 3 patents)

11. Elizabeth E Morgan (3 out of 3 patents)

12. Benoit Gourdet (2 out of 8 patents)

13. John Francis Unitt (2 out of 4 patents)

14. Timothy Phillips (2 out of 2 patents)

15. Lorna Duffy (2 out of 11 patents)

18 patents: Sort by Forward Citations

1. 11505550 - ADO-resistant cysteamine analogs and uses thereof (2022-11-22),

2. 11090279 - Delayed release cysteamine bead formulation, and methods of making and using same (2021-08-17),

3. 11020481 - Topical use of levofloxacin for reducing lung inflammation (2021-06-01),

4. 10987357 - Aerosolized fluoroquinolones and uses thereof (2021-04-27),

5. 10906904 - ADO-resistant cysteamine analogs and uses thereof (2021-02-02),

6. 10905662 - Methods for storing cysteamine formulations and related methods of treatment (2021-02-02),

7. 10792289 - Use of aerosolized levofloxacin for treating cystic fibrosis (2020-10-06),

8. 10722519 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2020-07-28),

9. 10548859 - Methods for storing Cysteamine formulations and related methods of treatment (2020-02-04),

10. 10328037 - Methods for storing cysteamine formulations and related methods of treatment (2019-06-25),

11. 10308607 - Fucosidase inhibitors (2019-06-04),

12. 10231975 - Use of aerosolized levofloxacin for treating cystic fibrosis (2019-03-19),

13. 10149854 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2018-12-11),

14. 10143665 - Methods for storing cysteamine formulations and related methods of treatment (2018-12-04),

15. 9951013 - Fucosidase inhibitors (2018-04-24),

Horizon Orphan LLC is a biotechnology company based in Lake Forest, Illinois, specializing in the development of innovative therapies for rare and orphan diseases. The organization focuses on advancing treatments that address unmet medical needs, leveraging cutting-edge research and technology in the pharmaceutical sector. With a commitment to improving patient outcomes, Horizon Orphan collaborates with various stakeholders to bring novel solutions to market, aiming to enhance the quality of life for individuals affected by these conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Horizon Orphan LLC

18 Patents

#18 in Lake Forest, IL

#915 in Illinois

#17,933 in US

#34,146 in the World

Lake Forest, IL, United States of America

Horizon Orphan LLC

Forward Citations = 35

23 inventors:

Michael N Dudley (8 out of 36 patents)

David C Griffith (8 out of 36 patents)

Olga Rodny (5 out of 27 patents)

4. Todd C Zankel (5 out of 16 patents)

5. Mark William Surber (4 out of 37 patents)

Please report any incorrect information to [email protected]

Loading…